AAAAAA
Results:
1-18
|
Results: 18
Authors:
Lansiaux, A
Laine, W
Baldeyrou, B
Mahieu, C
Wattez, N
Vezin, H
Martinez, FJ
Pineyro, A
Bailly, C
Citation: A. Lansiaux et al., DNA topoisomerase II inhibition by peroxisomicine A(1) and its radical metabolite induces apoptotic cell death of HL-60 and HL-60/MX2 human leukemia cells, CHEM RES T, 14(1), 2001, pp. 16-24
Authors:
Lansiaux, A
Bras-Goncalves, RA
Rosty, C
Laurent-Puig, P
Poupon, MF
Bailly, C
Citation: A. Lansiaux et al., Topoisomerase I-DNA covalent complexes in human colorectal cancer xenografts with different p53 and microsatellite instability status: Relation with their sensitivity to CTP-11, ANTICANC R, 21(1A), 2001, pp. 471-476
Authors:
Lansiaux, A
Facompre, M
Wattez, N
Hildebrand, MP
Bal, C
Demarquay, D
Lavergne, O
Bigg, DCH
Bailly, C
Citation: A. Lansiaux et al., Apoptosis induced by the homocamptothecin anticancer drug BN80915 in HL-60cells, MOLEC PHARM, 60(3), 2001, pp. 450-461
Authors:
Verdier-Pinard, P
Lansiaux, A
Bailly, C
Citation: P. Verdier-pinard et al., Combretastatin A4 phosphate, B CANCER, 88(3), 2001, pp. 235-239
Authors:
Dassonneville, L
Lansiaux, A
Wattelet, A
Wattez, N
Mahieu, C
Van Miert, S
Pieters, L
Bailly, C
Citation: L. Dassonneville et al., Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis, EUR J PHARM, 409(1), 2000, pp. 9-18
Authors:
Kluza, J
Lansiaux, A
Wattez, N
Mahieu, C
Osheroff, N
Bailly, C
Citation: J. Kluza et al., Apoptotic response of HL-60 human leukemia cells to the antitumor drug TAS-103, CANCER RES, 60(15), 2000, pp. 4077-4084
Authors:
Lansiaux, A
Bailly, C
Citation: A. Lansiaux et C. Bailly, JM216, an orally active platine derivative, B CANCER, 87(7-8), 2000, pp. 531-536
Authors:
Bailly, C
Lansiaux, A
Citation: C. Bailly et A. Lansiaux, An angiogenesis inhibitor: TNP-470, B CANCER, 87(6), 2000, pp. 449-454
Authors:
Lansiaux, A
Formstecher, P
Bailly, C
Citation: A. Lansiaux et al., LGD1069: an antagonist to the X retinoid receptor (rexinoid), B CANCER, 87(3), 2000, pp. 235-238
Authors:
Lansiaux, A
Bailly, C
Citation: A. Lansiaux et C. Bailly, Flavopiridol, a cyclin-dependent kinase inhibitor, B CANCER, 87(10), 2000, pp. 697-701
Authors:
Dassonneville, L
Wattez, N
Baldeyrou, B
Mahieu, C
Lansiaux, A
Banaigs, B
Bonnard, I
Bailly, C
Citation: L. Dassonneville et al., Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells, BIOCH PHARM, 60(4), 2000, pp. 527-537
Authors:
Lansiaux, A
Fabbro, D
Meyer, T
Hamy, F
Bailly, C
Citation: A. Lansiaux et al., PKC 412, B CANCER, 86(7-8), 1999, pp. 614-617
Authors:
Lansiaux, A
Henichart, JP
Bailly, C
Citation: A. Lansiaux et al., Bay-12-9566, B CANCER, 86(4), 1999, pp. 337-339
Authors:
Lansiaux, A
Bailly, C
Citation: A. Lansiaux et C. Bailly, NB 506, B CANCER, 86(3), 1999, pp. 255-258
Authors:
Lansiaux, A
Bailly, C
Citation: A. Lansiaux et C. Bailly, Ecteinascidin 743, B CANCER, 86(2), 1999, pp. 139-141
Authors:
Lansiaux, A
Adams, A
Denny, WA
Bailly, C
Citation: A. Lansiaux et al., The DACA, B CANCER, 86(12), 1999, pp. 971-975
Authors:
Lansiaux, A
Bailly, C
Citation: A. Lansiaux et C. Bailly, Dolastatins, B CANCER, 86(11), 1999, pp. 897-901
Authors:
Bailly, C
Lansiaux, A
Dassonneville, L
Demarquay, D
Coulomb, H
Huchet, M
Lavergne, O
Bigg, DCH
Citation: C. Bailly et al., Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks, BIOCHEM, 38(47), 1999, pp. 15556-15563
Risultati:
1-18
|